Oncology · research prototype
Anticancer treatment / between visits
Remote oncology monitoring —
over time.
A research system for observing symptoms and patient dynamics during outpatient cancer treatment, combining ePROs, wearable devices and professional review of prespecified signals.
Not a medical service. Does not diagnose, change anticancer treatment or replace the oncology team.
Demo stream
Synthetic dataA
Participant A-014Day 12 · outpatient treatment
StableReview signalActivity below personal baseline for two days
Not a diagnosisDeviceContextRuleProfessional
01 / Need
Why it matters
Symptoms and treatment tolerance may change between visits.
Wearable data do not replace the patient’s report. The research pathway connects ePRO symptoms with activity, sleep and heart-rate trends, then sends a prespecified signal to the responsible team for human review.
Oncology and evidence
Understand the technology before a pilot.
Independent English pages cover symptom monitoring, wearable measures, evidence limits and research design.
01 / PathwayRemote oncology monitoring
Symptoms, signal rules and accountable human review.
→02 / TechnologyWearables in oncologyActivity, sleep, heart rate, data quality and limitations.
→03 / SymptomsePRO in oncologyPatient-reported symptoms as a distinct evidence layer.
→04 / MethodsEvidence and inferenceWhat studies support—and what this prototype still needs to demonstrate.
→Scientific context
Evidence exists, but it is not interchangeable.
Randomised evidence exists for electronic symptom monitoring. Much wearable oncology research still focuses on feasibility, correlations and data quality. The project keeps these layers separate and makes no clinical-effect claim before its own study.
Methods and sources →ResidentSirius University of Science and Technology
Project operator
NPO Scientific Technologies LLC is a Sirius resident.
Participant status was obtained on 16 May 2025. It belongs to the legal entity and does not establish clinical validation or medical-device registration.
Monitoring pathway
A signal is not a decision.
Each step is auditable. The protocol sets the threshold and escalation route; an authorised professional remains responsible for any clinical action.
Device and ePRO
Passive measures are paired with brief patient reports of symptoms.
Personal context
Trends are considered against an individual baseline, not a universal norm.
±
Prespecified rule
The protocol defines the window, threshold and priority.
✓
Professional review
The team reviews context, contacts the patient and documents action.
Current boundary
Research prototype.
Not a medical service.
Interface concept
Synthetic stream, roles, signal pathway and legal information.
Separate validation
Protocol, ethics, devices, integrations and security review.
Real patient data
The website accepts no medical records, device feeds or patient questionnaires.
Autonomous decisions
No diagnosis, prescription, treatment change or automatic emergency response.
Key questions
Frequently asked
Is remote oncology monitoring currently available?
No. This is a research prototype with synthetic data; enrolment and device connection are not open.
Does the system diagnose or tell a patient what to do?
No. It is designed to surface a change for professional review, not to issue treatment advice.
Which wearable devices are supported?
No device has been selected. Documentation, data quality, intended use and regulatory status must be assessed for each protocol.
Can a clinic discuss a research pilot?
Yes, at protocol-design level and without sending patient data through this website or ordinary email.